Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
This comprehensive resource covers product change evaluation, postmarket surveillance, audit/inspection compliance, and various other laws and regulations pertaining to maintaining a product on the market.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Regulatory News | 03 March 2016 | By Zachary Brennan
The US Food and Drug Administration (FDA) on Thursday announced that it’s seeking more information on medical devices that are refurbished, reconditioned, rebuilt, remarketed, remanufactured, serviced or repaired in order to investigate a number of potential safety issues.
The call for more information comes as manufacturers of devices that are being refurbished by other companies have also requested clarification of their responsibilities when their devices have been altered.
“Stakeholders have expressed concerns that some third-party entities who refurbish, recondition, rebuild, remarket, remanufacture, service, and repair medical devices may use unqualified personnel to perform service, maintenance, refurbishment, and device alterations on their equipment and that the work performed may not be adequately documented,” FDA said. “Possible public health issues arising from these activities include ineffective recalls, disabled device safety features, and improper or unexpected device operation.”
FDA is interested in comments concerning the service, maintenance, refurbishment and alteration of medical devices, including endoscopes, some of which FDA has recalled in recent months because of contamination issues.
In addition, FDA says it wants to know more about the challenges third-party entities face in maintaining or restoring devices to their original or current specifications, though this docket for public comment is not intended to address the reprocessing of single-use or reusable medical devices.
The following questions address some of what FDA is interested in discussing on these devices: Who are the different stakeholders involved with these types of medical device activities? What are their respective roles? What evidence exists regarding actual problems with the safety and/or performance of devices that result from these activities? What are the potential risks (patients/users) and failure modes (devices) that result from performing the previously defined activities? What information do third-party entities need in order to perform these activities in a way that results in safe and effective operation of the medical device? Specific examples should be submitted, the agency says.
In addition to general comments, FDA is asking for assistance in defining and revising the definitions for the following terms:
FDA also said it intends to hold a public meeting later in 2016 to further engage the device industry and healthcare community.
Federal Register Notice
Tags: refurbished medical devices, remanufactured devices, refurbished medical equipment